, ,
doi.org/10.1007/s002620050582, hdl.handle.net/1765/60845
Cancer Immunology, Immunotherapy: other biological response modifications
Erasmus MC: University Medical Center Rotterdam

Kruit, W., Schmitz, P., & Stoter, G. (1999). The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon α and lymphokine-activated killer cells. Cancer Immunology, Immunotherapy: other biological response modifications, 48(6), 331–335. doi:10.1007/s002620050582